| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.14▼ | 1.14▼ | 1.14▼ | 1.11▼ | 1.17▼ |
| MA10 | 1.16▼ | 1.17▼ | 1.18▼ | 1.15▼ | 1.36▼ |
| MA20 | 1.24▼ | 1.26▼ | 1.26▼ | 1.21▼ | 1.58▼ |
| MA50 | 1.40▼ | 1.44▼ | 1.46▼ | 1.43▼ | 2.00▼ |
| MA100 | 1.69▼ | 1.70▼ | 1.67▼ | 1.59▼ | 3.30▼ |
| MA200 | 1.62▼ | 1.68▼ | 1.74▼ | 1.86▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.003▼ | -0.004▼ | 0.003▲ | -0.034▼ |
| RSI | 28.951▼ | 29.966▼ | 30.549▼ | 35.539▼ | 34.794▼ |
| STOCH | 11.640▼ | 3.968▼ | 2.629▼ | 8.607▼ | 7.023▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -95.844▼ | -99.237▼ |
| CCI | -147.967▼ | -134.979▼ | -132.782▼ | -128.297▼ | -85.942 |
|
Thursday, April 25, 2024 10:05 PM
Cybin (NYSE American: CYBN) (Cboe CA: CYBN) , a clinical-stage biopharmaceutical company developing new and innovative next-generation psychedelic-b ...
|
|
Thursday, April 25, 2024 12:30 PM
Merck & Co on Thursday raised its annual profit and revenue forecast on the back of strong sales for its blockbuster cancer drug Keytruda and human papillomavirus (HPV) vaccine Gardasil.
|
|
Thursday, April 25, 2024 10:58 AM
AbbVie's Upadacitinib outperforms dupilumab in Phase 3b/4 study for atopic dermatitis treatment, achieving superior efficacy and rapid skin clearance than Dupixent.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/04/24 | 1.10 | 1.1099 | 1.08 | 1.09 | 13,078 |
| 24/04/24 | 1.13 | 1.1966 | 1.09 | 1.09 | 3,222 |
| 23/04/24 | 1.1275 | 1.195 | 1.11 | 1.12 | 3,509 |
| 22/04/24 | 1.11 | 1.23 | 1.11 | 1.12 | 18,088 |
| 19/04/24 | 1.14 | 1.1661 | 1.11 | 1.12 | 5,974 |
| 18/04/24 | 1.19 | 1.2099 | 1.12 | 1.18 | 6,723 |
| 17/04/24 | 1.11 | 1.22 | 1.11 | 1.14 | 18,115 |
| 16/04/24 | 1.3206 | 1.3206 | 1.13 | 1.14 | 13,043 |
| 15/04/24 | 1.30 | 1.30 | 1.20 | 1.23 | 2,338 |
| 12/04/24 | 1.27 | 1.29 | 1.2001 | 1.27 | 11,268 |
|
|
||||
|
|
||||
|
|